Functionalized Lanthanide Oxide Nanoparticles for Tumor Targeting, Medical Imaging, and Therapy

Recent progress in functionalized lanthanide oxide (Ln2O3) nanoparticles for tumor targeting, medical imaging, and therapy is reviewed. Among the medical imaging techniques, magnetic resonance imaging (MRI) is an important noninvasive imaging tool for tumor diagnosis due to its high spatial resolution and excellent imaging contrast, especially when contrast agents are used. However, commercially available low-molecular-weight MRI contrast agents exhibit several shortcomings, such as nonspecificity for the tissue of interest and rapid excretion in vivo. Recently, nanoparticle-based MRI contrast agents have become a hot research topic in biomedical imaging due to their high performance, easy surface functionalization, and low toxicity. Among them, functionalized Ln2O3 nanoparticles are applicable as MRI contrast agents for tumor-targeting and nontumor-targeting imaging and image-guided tumor therapy. Primarily, Gd2O3 nanoparticles have been intensively investigated as tumor-targeting T1 MRI contrast agents. T2 MRI is also possible due to the appreciable paramagnetic moments of Ln2O3 nanoparticles (Ln = Dy, Ho, and Tb) at room temperature arising from the nonzero orbital motion of 4f electrons. In addition, Ln2O3 nanoparticles are eligible as X-ray computed tomography contrast agents because of their high X-ray attenuation power. Since nanoparticle toxicity is of great concern, recent toxicity studies on Ln2O3 nanoparticles are also discussed.

Methanation of CO2 over Cobalt-Lanthanide Aerogels: Effect of Calcination Temperature

High surface area cobalt-lanthanide bimetallic aerogels were successfully synthesized by the epoxide addition method. The bimetallic aerogels were calcined at two different temperatures and either bimetallic oxides containing oxychlorides, Co3O4.3LnOCl (Ln = La, Sm, Gd, Dy and Yb) or perovskites, LnCoO3 (Ln = La, Sm, Gd and Dy) were obtained at 500 or 900 °C, respectively. The exceptions are the aerogels of cerium and ytterbium, which after oxidation at 500 and 900 °C, stabilize as sesquioxides: Co3O4.3CeO2 and 2Co3O4.3Yb2O3, the first at both temperatures and the second only at the highest temperature. The bimetallic cobalt-lanthanide oxychlorides or perovskites were tested as catalysts for the methanation of CO2. The cobalt catalytic activity is determined by the type and acid-base properties of the lanthanide oxide phase and by its pre-reduction under hydrogen. The best results were those obtained over the calcined aerogels pre-reduced under hydrogen. In particular, the highest values were those obtained over the Co-Ce aerogel calcined at 900 °C that in the same conditions present an activity comparable to that measured over a 5 wt.% Rh catalyst supported on alumina, one of the literature references. The activity and the selectivity increase with the catalysts’ basicity, showing an inverse dependence of the reduction temperature that decreases along the lanthanide series either for the aerogels calcined at 500 or 900 °C. In general, the basicity of the aerogels calcined at 900 °C (perovskites) is higher and they are more active but less selective than those calcined at 500 °C (oxychlorides), which to our knowledge is for the first time reported for the methanation of CO2.

Intentional anion incorporation to rationally modulate the size, shape and optical properties of lanthanide oxide nanocrystals

Intentional anion incorporation has been proposed as an efficient route to rationally tune the size, morphology and optical properties of lanthanide oxide nanocrystals.

Novel lanthanide(III) 4-methylbenzoylhydrazide complexes as precursors for lanthanide oxide nanophotocatalysts

A series of metal complexes were prepared from separate reactions of lanthanide nitrate salts (La(iii), Ce(iii), Sm(iii), Gd(iii) and Ho(iii)) with 4-methylbenzoylhydrazide.